Canasa and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Canasa (mesalamine), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Humira, and have Crohn's disease.

The phase IV clinical study analyzes which people have Insomnia when taking Canasa. It is created by eHealthMe based on reports of 1,606 people who have side effects when taking Canasa from the FDA, and is updated regularly.

What is Canasa?

Canasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 1,676 Canasa users. Check the latest studies of Canasa.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,118 drugs and 5,169 conditions by eHealthMe. Check the latest studies of Insomnia.

On Jul, 08, 2026

1,606 people reported to have side effects when taking Canasa.
Among them, 26 people (1.62%) have Insomnia.

Among these 26 people:

How long have people been on Canasa when they have Insomnia? *

What is the gender of people who have Insomnia when taking Canasa? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Insomnia when taking Canasa? *

What are other drugs people take besides Canasa? *

What are other side effects people have besides Insomnia? *

Stress And Anxiety: 10 people, 38.46%
Diarrhea: 6 people, 23.08%
Muscle Spasms (muscle contraction): 6 people, 23.08%
Fatigue (feeling of tiredness): 6 people, 23.08%
Pain: 6 people, 23.08%
Abdominal Distension: 4 people, 15.38%
Haematochezia (passage of stools containing blood): 4 people, 15.38%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 15.38%
Fever: 4 people, 15.38%
Nausea (feeling of having an urge to vomit): 4 people, 15.38%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 11.54%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
High Blood Pressure: 2 people, 7.69%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.69%
Indigestion: 2 people, 7.69%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 7.69%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.69%
Asthma: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Canasa and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Canasa:

Canasa (1,676 reports)

Insomnia treatments and more:

Insomnia (438,078 reports)

Browse all side effects of Canasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,118 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,169 conditions)

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Canasa) and Canasa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.